{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Spirogermanium",
  "nciThesaurus": {
    "casRegistry": "41992-23-8",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A synthetic organometallic compound containing the element germanium with possible antineoplastic activity. Spirogermanium exhibits significant toxicity, particularly neurotoxicity.",
    "fdaUniiCode": "1F01P3Y61E",
    "identifier": "C1232",
    "preferredName": "Spirogermanium",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2139"
    ],
    "synonyms": [
      "2-[3-(Dimethyl-amino)propyl]-8,8-diethyl-2-aza-8-germaspiro[4,5]decane",
      "8,8-Diethyl-N,N-dimethyl-3-aza-8-germaspiro[4,5]decane-2-propanamine",
      "S 99 A",
      "SPG",
      "SPIROGERMANIUM",
      "Spiro 32",
      "Spiro-32",
      "Spirogermanium",
      "Spirogermanium Compound",
      "Spirogermanium compound"
    ]
  }
}